Revenue GrowthSustained ~15.8% top-line growth in 2025 indicates improving product demand and market traction. Over the next 2–6 months this supports scale benefits, revenue diversification and the potential to leverage fixed costs toward higher operating leverage if cost control continues.

Gross Margin StabilityStable gross margins near 39–41% suggest consistent product economics and pricing power versus input cost swings. That structural margin stability provides a foundation for durable profitability improvement if the company tightens operating expenses or realizes scale from higher revenues.

Return To Profitability (2025)A return to positive net income in 2025, even modest, reduces existential risk and improves access to lenders and equity markets. Sustained profitability, coupled with revenue growth, can restore confidence and fund gradual deleveraging if cash generation improves.

Bears Say

High LeverageA marked rise in leverage to ~2.6x D/E materially increases financial risk and interest burden. With thin margins and volatile cash flow, elevated debt constrains strategic flexibility, heightens refinancing risk during stress, and limits ability to invest in growth without deleveraging.

Persistent Negative Cash FlowRepeated negative operating and free cash flow signals structural working-capital or earning-quality issues. Reliance on external financing to fund operations weakens resilience, raises liquidity risk, and can hamper long-term investment, dividend capacity, and debt reduction plans.

Very Thin ProfitabilityMargins around 0.5% net and ~1.3% EBIT leave minimal buffer for cost inflation or demand shocks. Thin profitability limits internal reinvestment, reduces return on capital, and means small adverse changes in costs or volumes can quickly revert the firm to losses.

4935 FAQ

What was Liberta Co., Ltd.’s price range in the past 12 months?

Liberta Co., Ltd. lowest stock price was ¥194.80 and its highest was ¥844.00 in the past 12 months.

What is Liberta Co., Ltd.’s market cap?

Liberta Co., Ltd.’s market cap is ¥10.47B.

When is Liberta Co., Ltd.’s upcoming earnings report date?

Liberta Co., Ltd.’s upcoming earnings report date is May 20, 2026 which is in 72 days.

How were Liberta Co., Ltd.’s earnings last quarter?

Liberta Co., Ltd. released its earnings results on Feb 13, 2026. The company reported ¥7.876 earnings per share for the quarter, beating the consensus estimate of N/A by ¥7.876.

Is Liberta Co., Ltd. overvalued?

According to Wall Street analysts Liberta Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Liberta Co., Ltd. pay dividends?

Liberta Co., Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of 0.48%. See more information on Liberta Co., Ltd. dividends here

What is Liberta Co., Ltd.’s EPS estimate?

Liberta Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Liberta Co., Ltd. have?

Liberta Co., Ltd. has 30,262,600 shares outstanding.

What happened to Liberta Co., Ltd.’s price movement after its last earnings report?

Liberta Co., Ltd. reported an EPS of ¥7.876 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.161%.

Which hedge fund is a major shareholder of Liberta Co., Ltd.?

Currently, no hedge funds are holding shares in JP:4935

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Liberta Co., Ltd.

Liberta Co., Ltd. (4935) is a Japanese company primarily engaged in the development, manufacturing, and sale of healthcare products, focusing on innovative solutions for skin health and personal care. The company operates in the pharmaceutical and cosmetic sectors, providing a range of products that include topical treatments, skincare formulations, and health supplements. Liberta is committed to leveraging advanced research and technology to enhance consumer well-being and promote healthier skin.